{
  "html_url": "https://licitia.com.mx/adjudicacion/aa-12-nbv-012nbv001-i-348-2023",
  "canonical": "https://licitia.com.mx/adjudicacion/aa-12-nbv-012nbv001-i-348-2023",
  "id": "6df1ef49e7404d11bae7960d9418ce69",
  "procedure_number": "AA-12-NBV-012NBV001-I-348-2023",
  "file_number": "E-2023-00108624",
  "title": "ADQUISICIÓN DE KITS DE MEDICIÓN DE ANTICUERPOS SARS COV2",
  "description": {
    "short": "Adquisiciones, arrendamientos y servicios, dentro de los montos máximos establecidos en el PEF.",
    "detailed": "LOS PACIENTES CON ENFERMEDADES  HEMATOLÓGICAS, ESPECÍFICAMENTE  LOS PACIENTES CON LINFOMA NO HODNKIN QUE RECIBEN TERAPIA CON ANTICUERPOS MONOCLONALES  ANTI -CD20  TIENEN MAYOR  RIESGO DE TENER  PERSISTENCIA EN LA REPLICACIÓN  VIRAL  Y  DESARROLLAR  ANTICUERPOS CONTRA SARS COV2  ESTOS PACIENTES SIGUEN PRESENTÁNDOSE CON FORMAS GRAVES DE LA ENFERMEDAD.  EN ESTOS PACIENTES SE HA VISTO  UN BENEFICIO DE ADMINISTRARLES PLASMA CONVALECIENTE CON TÍTULOS ALTOS DE ANTICUERPOS  NEUTRALIZANTES CONTRA SARS COV2. ES NECESARIO MEDIR LA CANTIDAD DE ANTICUERPOS  NEUTRALIZANTES EN LOS POTENCIALES DONADORES, PARA GARANTIZAR QUE EL PLASMA TRANSFUNDIDO CONTENGA  TÍTULOS ALTOS DE ANTICUERPOS"
  },
  "lifecycle": {
    "section": "concluido",
    "source_status": "ADJUDICADO",
    "moved_at": null
  },
  "buyer": {
    "agency": "INCAN",
    "acronym": "INCAN",
    "branch": "12 - SALUD",
    "buying_unit": "DIRECCION DE ADMINISTRACION",
    "requesting_unit": "unidad requiriente data",
    "requesting_group": "DIRECCION DE ADMINISTRACION",
    "entity": "instituto nacional de cancerología",
    "slug": "incan",
    "unit_slug": "direccion-de-administracion-012nbv001"
  },
  "classification": {
    "procedure_type": "ADJUDICACIÓN DIRECTA",
    "contracting_type": "ADQUISICIONES",
    "publication_type": null,
    "character": "INTERNACIONAL ABIERTO",
    "fiscal_year": 2023,
    "law": "LEY DE ADQUISICIONES, ARRENDAMIENTOS Y SERVICIOS DEL SECTOR PÚBLICO",
    "legal_basis_id": "42",
    "exception_basis": "Art. 42 párrafo primero",
    "internal_control_number": "ADQUISICIÓN DE KITS DE MEDICIÓN DE ANTICUERPOS SARS COV2",
    "supply_source_number": null
  },
  "schedule": {
    "published_at": "2024-12-31T20:16:16.000Z",
    "clarification_meeting_at": null,
    "clarification_questions_deadline_at": null,
    "clarification_responses_deadline_at": null,
    "bid_opening_at": null,
    "award_at": null,
    "estimated_contract_at": "2023-10-16T06:00:00.000Z",
    "site_visit_at": null,
    "estimated_work_start_at": null
  },
  "estimated_value": {
    "minimum": null,
    "maximum": null,
    "currency": "MXN",
    "updated_at": null
  },
  "lots": [
    {
      "number": "1",
      "name": "PARTIDA SOLA",
      "description": "PARTIDA SOLA",
      "requirement_group_id": "1",
      "items": [
        {
          "number": "1",
          "cucop_code": "25301-3575",
          "specific_item_code": "25301",
          "cucop_description": "PRUEBA DE DETECCION DEL SARS-COV-2 (COVID-19)",
          "description": "SARS-COV-2 SURROGATE VIRUS NEUTROLIZATION TEST (SVNT) KIT, GENSCRIPT        (UNIDAD DE MEDIDA KIT)",
          "requested_quantity": "2",
          "minimum_quantity": "2",
          "maximum_quantity": null,
          "unit": "PIEZA",
          "minimum_amount": null,
          "maximum_amount": null
        },
        {
          "number": "2",
          "cucop_code": "25301-3575",
          "specific_item_code": "25301",
          "cucop_description": "PRUEBA DE DETECCION DEL SARS-COV-2 (COVID-19)",
          "description": "SARS-COV-2 SPIKE PROTEIN RBD-HRP, BA.2 VARIANT, HIS TAG, GENSCRIPT       (UNIDAD DE MEDIDA KIT)",
          "requested_quantity": "2",
          "minimum_quantity": "2",
          "maximum_quantity": null,
          "unit": "PIEZA",
          "minimum_amount": null,
          "maximum_amount": null
        }
      ]
    }
  ],
  "awards": [
    {
      "id": "C-2023-00138867",
      "internal_reference": "P23-000302",
      "title": "ADQUISICIÓN DE KITS DE MEDICIÓN DE ANTICUERPOS SARS COV2",
      "status": "PUBLICADO",
      "contractor": {
        "name": "BRI BIORESEARCH SA DE CV",
        "normalized_name": "BRI BIORESEARCH",
        "rfc_type": null,
        "slug": "bri-bioresearch"
      },
      "contract_period": {
        "published_at": "2024-12-31T20:16:16.000Z",
        "starts_at": "2023-10-16T06:00:00.000Z",
        "ends_at": "2023-12-31T06:00:00.000Z"
      },
      "value": {
        "subtotal": "70554",
        "tax": "11288.64",
        "total": "81842.64",
        "maximum_subtotal": "0",
        "maximum_total": "0",
        "currency": "MXN"
      },
      "open_contract_type": null,
      "quantity": null,
      "exercised_quantity": null,
      "participants": [],
      "line_items": [
        {
          "number": "0",
          "cucop_code": "25301-3575",
          "description": "SARS-COV-2 SURROGATE VIRUS NEUTROLIZATION TEST (SVNT) KIT, GENSCRIPT        (UNIDAD DE MEDIDA KIT)",
          "unit": "PIEZA",
          "requested_quantity": "2",
          "awarded_quantity": null,
          "unit_price": "23000",
          "subtotal": "46000",
          "tax": "7360",
          "other_taxes": null,
          "total": "53360"
        },
        {
          "number": "0",
          "cucop_code": "25301-3575",
          "description": "SARS-COV-2 SPIKE PROTEIN RBD-HRP, BA.2 VARIANT, HIS TAG, GENSCRIPT       (UNIDAD DE MEDIDA KIT)",
          "unit": "PIEZA",
          "requested_quantity": "2",
          "awarded_quantity": null,
          "unit_price": "12277",
          "subtotal": "24554",
          "tax": "3928.64",
          "other_taxes": null,
          "total": "28482.64"
        }
      ]
    }
  ],
  "documents": [
    {
      "id": null,
      "annex_number": 1,
      "document_type": null,
      "description": "ANEXO TÉCNICO",
      "filename": "anexo tecnico bueno.pdf",
      "availability": "available",
      "size_bytes": "1427965",
      "mime_type": "application/pdf",
      "sha256": null,
      "uploaded_at": "2025-11-18T15:56:08.178Z",
      "updated_at": "2025-11-18T15:56:08.179Z"
    },
    {
      "id": null,
      "annex_number": 3,
      "document_type": null,
      "description": "OFICIO DE ADJUDICACIÓN",
      "filename": "adjudicaciÃ³n.pdf",
      "availability": "available",
      "size_bytes": "579292",
      "mime_type": "application/pdf",
      "sha256": null,
      "uploaded_at": "2025-11-18T15:56:10.425Z",
      "updated_at": "2025-11-18T15:56:10.427Z"
    }
  ],
  "alternates": [],
  "similar": [
    {
      "numero_procedimiento": "aa-12-nbv-012nbv001-n-210-2024",
      "nombre_procedimiento": "ADQUISICION DE  PRUEBAS ANTIGENICAS SARS-COV-2",
      "dependencia": "INCAN",
      "siglas": "INCAN",
      "score": 0.14859473705291748
    },
    {
      "numero_procedimiento": "aa-12-nbv-012nbv001-i-68-2023",
      "nombre_procedimiento": "ADQUISICIÓN DE PRUEBAS ANTIGENICAS RAPIDAS PARA LA DETECCION DE SARS-COV-2",
      "dependencia": "INCAN",
      "siglas": "INCAN",
      "score": 0.1486996919691731
    },
    {
      "numero_procedimiento": "aa-12-nbg-012nbg003-n-348-2023",
      "nombre_procedimiento": "RM-AF-792/23",
      "dependencia": "HIM",
      "siglas": "HIM",
      "score": 0.15677139630232406
    },
    {
      "numero_procedimiento": "aa-12-nbd-012nbd001-i-295-2023",
      "nombre_procedimiento": "ADQUISICIÓN DE PRUEBAS PARA DETECCION DE COVID-19",
      "dependencia": "HOSPITAL GENERAL DE MÉXICO \"DR. EDUARDO LICEAGA\"",
      "siglas": "HGM",
      "score": 0.16201317310333252
    },
    {
      "numero_procedimiento": "aa-12-ncd-012ncd001-i-149-2024",
      "nombre_procedimiento": "REACTIVOS EXPERIMENTALES PARA SEPARACION DE MUESTRAS DE PLASMA Y CELULAS",
      "dependencia": "INER",
      "siglas": "INER",
      "score": 0.16210906166813
    },
    {
      "numero_procedimiento": "aa-12-nck-012nck001-n-21-2023",
      "nombre_procedimiento": "MEDICINAS Y PRODUCTOS FARMACÉUTICOS",
      "dependencia": "INNN",
      "siglas": "INNN",
      "score": 0.16334646940231323
    }
  ]
}